An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Severe Acute Respiratory Syndrome - Coronavirus - 2 (SARS-CoV-2) and its related Coronavirus Disease - 19 (COVID-19) has become a health emergency worldwide. The medical community has been concerned since the beginning of the outbreak about the potential impact of COVID-19 in children, especially in those with underlying chronic diseases. Fortunately, COVID-19 has been reported to be less severe in children than in adults. However, epidemiologic and clinical data are scarce. Children show unique features of SARS-CoV-2 involvement that may account for the low rate of infection and death in this age group. The purpose of this review is to summarize the most relevant evidence of COVID-19 in children highlighting similarities and differences with adults.
Fitzgerald DA, Maclean J, Rubin BK.Fitzgerald DA, et al.Paediatr Respir Rev. 2020 Sep;35:1-2. doi: 10.1016/j.prrv.2020.06.017. Epub 2020 Jun 27.Paediatr Respir Rev. 2020.PMID: 32819831Free PMC article.No abstract available.
References
Fan Y., Zhao K., Shi Z.L., Zhou P. Bat coronaviruses in China. Viruses. 2019;11:27–32. doi: 10.3390/v11030210.
-
DOI
-
PMC
-
PubMed
Zhou P., Lou Yang X, Wang X.G., Hu B., Zhang L., Zhang W. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi: 10.1038/s41586-020-2012-7.
-
DOI
-
PMC
-
PubMed
Zimmerman P., Curtis N. Coronavirus infections in children including COVID- 19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020:1–14. doi: 10.1097/INF.0000000000002660.
-
DOI
-
PMC
-
PubMed
Anderson R.M., Fraser C., Ghani A.C., Donnelly C.A., Riley S., Ferguson N.M. Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic. Philos Trans R Soc B Biol Sci. 2004;359:1091–1105. doi: 10.1098/rstb.2004.1490.
-
DOI
-
PMC
-
PubMed
Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020:1–10. doi: 10.1016/j.cell.2020.02.052.
-
DOI
-
PMC
-
PubMed